These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1976294)

  • 1. Prostaglandins and gastric ulcers: from seminal vesicle to misoprostol (Cytotec).
    Feldman M
    Am J Med Sci; 1990 Aug; 300(2):116-32. PubMed ID: 1976294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
    Miederer SE
    Fortschr Med; 1989 Mar; 107(10):63-4, 67-8. PubMed ID: 2497057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin treatment for peptic ulcer.
    Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():40-9. PubMed ID: 2906468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotec (misoprostol).
    Swartz ML
    Gastroenterol Nurs; 1990; 13(1):37-9. PubMed ID: 2126958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties.
    Jones JB; Bailey RT
    DICP; 1989 Apr; 23(4):276-82. PubMed ID: 2499129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
    Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
    Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 14. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 analogue therapy in the treatment of refractory gastric ulcer in an elderly patient.
    Ramsey EJ; Harris AE
    Arch Intern Med; 1988 Oct; 148(10):2275-6. PubMed ID: 3140754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
    Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
    Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandins and damage to the gastric mucosa].
    Varró V
    Orv Hetil; 1991 Jul; 132(27):1461-7. PubMed ID: 1683479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of nizatidine and misoprostol on peptic activity and gastric mucus].
    Grassi SA; Vianello F; Germanà B; Dal Santo P; Faggian D; Battaglia G; Plebani M; Di Mario F; Naccarato R
    Medicina (Firenze); 1990; 10(1):29-31. PubMed ID: 1974318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.